Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

被引：0
|
作者：
Nils Venhoff
Wolfgang A. Schmidt
Peter Lamprecht
Hans-Peter Tony
Christine App
Christian Sieder
Carolin Legeler
Claudia Jentzsch
Jens Thiel
机构：
[1] Klinik für Rheumatologie und Klinische Immunologie,Department Innere Medizin
[2] Vaskulitiszentrum Freiburg,Department of Immunology, Hepatology & Dermatology
[3] Universitätsklinikum Freiburg,undefined
[4] Immanuel Krankenhaus Berlin,undefined
[5] Klinik für Innere Medizin,undefined
[6] Abteilung Rheumatologie und Klinische Immunologie in Berlin-Buch,undefined
[7] Universität zu Lübeck,undefined
[8] Klinik für Rheumatologie und klinische Immunologie,undefined
[9] Medizinische Klinik II,undefined
[10] Universitätsklinik,undefined
[11] Rheumatology/Immunology,undefined
[12] Novartis Pharma GmbH,undefined
[13] Novartis Pharma AG,undefined
来源：
Trials | / 22卷
关键词：
Giant cell arteritis; Secukinumab; Phase II trial; Placebo; Double-blind;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
    Yoshifuji, Hajime
    Ishii, Tomonori
    Ohashi, Hiroki
    Yoshizawa, Katsunori
    Mihoya, Maki
    Nishikawa, Kazuko
    Nakaoka, Yoshikazu
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2025, 9 (02)
  • [22] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Liang Dai
    Linda L. D. Zhong
    Yan Cao
    Wei Chen
    Ying Cheng
    Xiu-Fang Lin
    Zhao-Xiang Bian
    Ai-Ping Lu
    Trials, 17
  • [23] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Chen, Qi
    Wang, Zi
    Lv, Jicheng
    Liu, Lijun
    Li, Hang
    Sun, Weiwei
    Huo, Yanhong
    Guo, Yingbo
    Shen, Cun
    Li, Shichao
    Chen, Zhenjie
    Zhou, Jingwei
    TRIALS, 2022, 23 (01)
  • [24] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
    Qi Chen
    Zi Wang
    Jicheng Lv
    Lijun Liu
    Hang Li
    Weiwei Sun
    Yanhong Huo
    Yingbo Guo
    Cun Shen
    Shichao Li
    Zhenjie Chen
    Jingwei Zhou
    Trials, 23
  • [25] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Dai, Liang
    Zhong, Linda L. D.
    Cao, Yan
    Chen, Wei
    Cheng, Ying
    Lin, Xiu-Fang
    Bian, Zhao-Xiang
    Lu, Ai-Ping
    TRIALS, 2016, 17
  • [26] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
  • [27] A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
    Hoffman, GS
    Cid, MC
    Hellman, DB
    Guillevin, L
    Stone, JH
    Schousboe, J
    Cohen, P
    Calabrese, LH
    Dickler, H
    Merkel, PA
    Fortin, P
    Flynn, JA
    Locker, GA
    Easley, KA
    Schned, E
    Hunder, GG
    Sneller, MC
    Tuggle, C
    Swanson, H
    Hernández-Rodríguez, J
    Lopez-Soto, A
    Bork, D
    Hoffman, DB
    Kalunian, K
    Klashman, D
    Wilke, WS
    Scheetz, RJ
    Mandell, BF
    Fessler, BJ
    Kosmorsky, G
    Prayson, R
    Luqmani, RA
    Nuki, G
    McRorie, E
    Sherrer, Y
    Baca, S
    Walsh, B
    Ferland, D
    Soubrier, M
    Choi, HK
    Gross, W
    Segal, AM
    Ludivico, C
    Puechal, X
    ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1309 - 1318
  • [28] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
    Reetz, Kathrin
    Hilgers, Ralf-Dieter
    Isfort, Susanne
    Dohmen, Marc
    Didszun, Claire
    Fedosov, Kathrin
    Kistermann, Jennifer
    Mariotti, Caterina
    Durr, Alexandra
    Boesch, Sylvia A.
    Klopstock, Thomas
    Garrido, Francisco Javier Rodriguez de Rivera
    Schoels, Ludger
    Klockgether, Thomas
    Pandolfo, Massimo
    Korinthenberg, Rudolf
    Lavin, Philip
    Molenberghs, Geert
    Libri, Vincenzo
    Giunti, Paola
    Festenstein, Richard
    Schulz, Joerg B.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2019, 1 (01):
  • [29] Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
    Kathrin Reetz
    Ralf-Dieter Hilgers
    Susanne Isfort
    Marc Dohmen
    Claire Didszun
    Kathrin Fedosov
    Jennifer Kistermann
    Caterina Mariotti
    Alexandra Durr
    Sylvia Boesch
    Thomas Klopstock
    Francisco Javier Rodríguez de Rivera Garrido
    Ludger Schöls
    Thomas Klockgether
    Massimo Pandolfo
    Rudolf Korinthenberg
    Philip Lavin
    Geert Molenberghs
    Vincenzo Libri
    Paola Giunti
    Richard Festenstein
    Jörg B. Schulz
    Neurological Research and Practice, 1
  • [30] Efficacy and Safety of Useul for Dry Eye Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled, Parallel, Phase 2 Clinical Trial
    Lyu, Yee-Ran
    Kwon, O-Jin
    Park, Bongkyun
    Jung, Hyun-A
    Lee, Ga-Young
    Kim, Chan-Sik
    HEALTHCARE, 2024, 12 (23)
12345